For over a year now, in cooperation with OncoBeta, DSD-Pharma has recorded successes in the therapy of non-melanoma skin cancer (NMSC) in Austria.
The Institute of Nuclear Medicine Ottakring Clinic in Vienna has been offering Rhenium-Skin Cancer Therapy (Re-SCT®) since 2021 under the direction of Prof. Siroos Mirzaei.
From 2023, Re-SCT® will be available at the Nuclear Medicine Institute of the Kepler University Hospital Linz, followed by further treatment options in Vienna and other provinces.
